MOH — authorised 17 December 1990
- Marketing authorisation holder: RANBAXY
- Status: likely_approved
MOH authorised Ultravate on 17 December 1990
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 17 December 1990.
RANBAXY holds the Israeli marketing authorisation.